Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Divestments (2021 - 2023)

Historic Divestments for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 3 years, with Q2 2023 value amounting to $1.0 million.

  • Lifecore Biomedical, Inc. \De\'s Divestments fell 9646.13% to $1.0 million in Q2 2023 from the same period last year, while for Feb 2024 it was $1.0 million, marking a year-over-year decrease of 9771.93%. This contributed to the annual value of $16.7 million for FY2023, which is 7731.84% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Divestments amounted to $1.0 million in Q2 2023, which was down 9646.13% from $12.5 million recorded in Q1 2023.
  • Lifecore Biomedical, Inc. \De\'s 5-year Divestments high stood at $45.1 million for Q3 2021, and its period low was $1.0 million during Q2 2023.
  • Over the past 3 years, Lifecore Biomedical, Inc. \De\'s median Divestments value was $12.5 million (recorded in 2023), while the average stood at $18.0 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Divestments plummeted by 9304.88% in 2022 and then tumbled by 9646.13% in 2023.
  • Over the past 3 years, Lifecore Biomedical, Inc. \De\'s Divestments (Quarter) stood at $45.1 million in 2021, then plummeted by 93.05% to $3.1 million in 2022, then crashed by 67.94% to $1.0 million in 2023.
  • Its Divestments was $1.0 million in Q2 2023, compared to $12.5 million in Q1 2023 and $3.1 million in Q3 2022.